CClinicalTrials.gg
Status unknownNCT03286491Updated Sep 18, 2017

Clinical Decision Support System to Define 30 Day Adverse Clinical Events for Emergency Department Acute Coronary Syndromes

An observational study in Acute Coronary Syndrome and Clinical Decision Support System, sponsored by Turkish Ministry of Health Izmir Teaching Hospital. Status unknown at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-09-18.

Sponsored by Turkish Ministry of Health Izmir Teaching Hospital · Observational

The sponsor has not verified this record recently (last verified Sep 2017), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
400
Ages
18 Years and older
Sex
All
01

Study summary

Acute coronary syndromes are among main complains for patients presenting to emergency department. Risk classification systems are used to classify patients to appropriate risks and help physicians manage diagnosis strategies and treatments. Purpose of this study is to develop a clinical decision support system for patients presenting to emergency department with the help of statistical machine learning.

Read the detailed description

Acute coronary syndromes are among main complains for patients presenting to emergency department and create a burden to emergency departments and hospitals. Risk classification systems were developed and used to classify patients to appropriate risk groups. According to risk classification, different diagnosis and treatment modalities can be used and help physicians manage diagnosis strategies and treatments. Purpose of this study is to develop a clinical decision support system for patients presenting to emergency department with the help of statistical machine learning.

02

Conditions studied

  • Acute Coronary Syndrome
  • Clinical Decision Support System

Keywords

  • acute coronary syndrome, risk classification, 30 day adverse event, clinical decision support system
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

Patients presenting to emergency deparmtent with acute chest pain consistent with acute coronary syndrome will be included for analysis.

Inclusion criteria

  • Presenting to emergency department with acute chest pain consistent with acute coronary syndrome

Exclusion criteria

Exclusion Criteria:

  • Patients with less than 18 years old
  • Patients presenting with ST-segment elevation myocardial infarction
  • Patients presenting with other causes of acute chest pain (pneumothorax, pulmonary -embolism, aortic dissection
  • Decline to participate in study
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
400 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients presenting with acute coronary syndrome

    Patients presenting to emergency department with acute coronary syndrome

    Diagnostic Test: Further cardiac imaging

Interventions

  • Diagnostic testFurther cardiac imaging

    Study patients will be reviewed whether they will have coronary interventions in 30 days

05

What researchers measure

Primary outcomes

  1. Non fatal myocardial infarction, cardiac related death or coronary intervention in 30 days

    Patients will be screened for 30 days for Non fatal myocardial infarction, cardiac related death or coronary intervention (coronary angiogram, coronary artery bypass surgery)

    Time frame: 30 days

06

Study locations

1 of 1 sites recruiting
  • Izmir Bozyaka Training and Research Hospital
    Izmir, 35000, Turkey
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03286491
Lead sponsor
Turkish Ministry of Health Izmir Teaching Hospital
Responsible party
Serhat Akay (M.D., Turkish Ministry of Health Izmir Teaching Hospital) — Principal investigator
First posted
Sep 18, 2017
Start date
Aug 12, 2017
Primary completion
Dec 12, 2017 (estimated)
Completion
Feb 1, 2018 (estimated)
Last update
Sep 18, 2017

Study contacts

Nesli Belen, M.D.
Contact
neslibelen@yahoo.com
90-551-4363001
Serhat Akay, M.D.
Contact
howls_Castle@mynet.com
90-505-7079350

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion